Your session is about to expire
← Back to Search
Genetic Testing
Genetic Testing for Cancer Risk
N/A
Recruiting
Led By Niloy J Samadder
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients at least 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study completion (2 years)
Awards & highlights
Study Summary
This trial looks at how well cancer genetic testing works in different ethnic groups. It could help find cancer genes and other people at risk. The info could also help with cancer risk stratification ( figuring out who is most likely to get cancer) and individualized screening ( tests specifically for the person being tested).
Who is the study for?
This trial is for adults from diverse ethnic backgrounds, including Hispanic/Latino, Native American/Alaskan, African American, Asian and European descent who have solid tumor cancers. They must be able to provide a blood sample and agree to genetic testing at Mayo Clinic in Arizona or Florida.Check my eligibility
What is being tested?
The study focuses on collecting biospecimens and conducting genetic tests among various ethnic groups. It aims to identify cancer genes for better risk assessment and personalized screening strategies.See study design
What are the potential side effects?
There are generally no direct side effects from participating in this trial as it involves non-invasive procedures like blood collection and genetic testing.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ study completion (2 years)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study completion (2 years)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Impact of germline genetic testing on both therapeutic management and targeted cancer prevention
Prevalence of pathogenic germline mutations in enrolled patients within each cancer site
Prevalence of positive pathogenic germline mutations
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Screening (biospecimen collection)Experimental Treatment2 Interventions
Patients undergo collection of blood or saliva sample for genetic testing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 2
~1730
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,660 Previous Clinical Trials
40,922,721 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,765,340 Total Patients Enrolled
Niloy J SamadderPrincipal InvestigatorMayo Clinic
5 Previous Clinical Trials
1,265 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.You are from certain ethnic backgrounds such as Hispanic/Latino, Native American/Alaskan, African American, Asian, and other European populations.I have been diagnosed with a solid tumor cancer and am seeking treatment at Mayo Clinic.I had a genetic test with 40+ genes at Mayo Clinic in the last 2 years, and the results can be reviewed.I can safely provide the needed blood samples.I have or had blood cancer, like leukemia or multiple myeloma.I have had a bone marrow transplant.
Research Study Groups:
This trial has the following groups:- Group 1: Screening (biospecimen collection)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the uppermost limit on participants in this clinical trial?
"Affirmative. According to details posted on clinicaltrials.gov, this medical trial is presently recruiting patients that were first listed on November 21st 2019 and last updated September 1st 2022. 600 individuals need to be sourced from 2 distinct sites."
Answered by AI
Is there still availability for enrollment in this research program?
"Clinicaltrials.gov reports that this study is seeking participants, with the first posting on November 21st 2019 and its most recent update being September 1st 2022."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger